Rafferty Asset Management, LLC Revolution Medicines, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 167,839 shares of RVMD stock, worth $9.48 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

167,839

Previous 185,637 9.59%

Holding current value

$9.48 Million

Previous $7.2 Million 5.55%

% of portfolio

0.03%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$36.92 - $47.94 $657,102 - $853,236	-17,798 Reduced 9.59%	167,839 $7.6 Million
Q2 2024 Aug 13, 2024	SELL	$30.14 - $40.68 $2.98 Million - $4.02 Million	-98,715 Reduced 34.72%	185,637 $7.2 Million
Q1 2024 May 13, 2024	SELL	$26.56 - $33.55 $2.14 Million - $2.71 Million	-80,743 Reduced 22.12%	284,352 $9.16 Million
Q4 2023 Feb 13, 2024	BUY	$18.35 - $34.12 $2.54 Million - $4.71 Million	138,153 Added 60.88%	365,095 $10.5 Million
Q3 2023 Nov 13, 2023	SELL	$25.17 - $35.05 $2.47 Million - $3.43 Million	-98,001 Reduced 30.16%	226,942 $6.28 Million
Q2 2023 Aug 11, 2023	SELL	$20.28 - $27.0 $53,600 - $71,361	-2,643 Reduced 0.81%	324,943 $8.69 Million
Q1 2023 May 11, 2023	BUY	$20.76 - $30.09 $1.87 Million - $2.72 Million	90,268 Added 38.04%	327,586 $7.1 Million
Q4 2022 Feb 13, 2023	SELL	$17.68 - $25.53 $539,858 - $779,558	-30,535 Reduced 11.4%	237,318 $5.65 Million
Q3 2022 Nov 14, 2022	BUY	$17.46 - $26.0 $2.88 Million - $4.29 Million	164,852 Added 160.05%	267,853 $5.28 Million
Q2 2022 Aug 12, 2022	SELL	$14.54 - $27.17 $663,329 - $1.24 Million	-45,621 Reduced 30.7%	103,001 $2.01 Million
Q1 2022 May 13, 2022	SELL	$17.31 - $26.4 $154,249 - $235,250	-8,911 Reduced 5.66%	148,622 $3.79 Million
Q4 2021 Feb 10, 2022	BUY	$24.35 - $33.7 $1.42 Million - $1.96 Million	58,257 Added 58.68%	157,533 $3.97 Million
Q3 2021 Nov 10, 2021	BUY	$23.95 - $33.41 $554,729 - $773,842	23,162 Added 30.43%	99,276 $2.73 Million
Q2 2021 Aug 10, 2021	BUY	$29.0 - $47.44 $176,146 - $288,150	6,074 Added 8.67%	76,114 $2.42 Million
Q1 2021 May 10, 2021	BUY	$37.21 - $54.43 $2.01 Million - $2.94 Million	53,992 Added 336.44%	70,040 $3.21 Million
Q4 2020 Feb 10, 2021	SELL	$30.19 - $45.49 $73,512 - $110,768	-2,435 Reduced 13.17%	16,048 $635,000
Q3 2020 Nov 13, 2020	BUY	$22.61 - $34.8 $417,900 - $643,208	18,483 New	18,483 $643,000

Others Institutions Holding RVMD

# of Institutions

266

Shares Held

161M

Call Options Held

260K

Put Options Held

620K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $4.95B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Revolution Medicines, Inc. Transaction History